White problem gamblers discount delayed rewards less steeply than their African American and Hispanic counterparts.

Leonardo F Andrade, Nancy M Petry
Author Information
  1. Leonardo F Andrade: Contingency Management, University of Connecticut School of Medicine.
  2. Nancy M Petry: Department of Medicine, Calhoun Cardiology Center, University of Connecticut Health Center.

Abstract

Impulsivity is a core process underlying addictive behaviors, including nonpharmacological addictive behaviors such as problem gambling. Although considerable attention has been given to the investigation of delay discounting within the context of addiction-related behaviors, relatively little research has examined the relationship between discounting and individual variables, such as race/ethnicity. The purpose of this study was to compare discounting rates in the three most prevalent racial/ethnic groups in the United States: Whites, African Americans, and Hispanics. The study was conducted with 315 problem gamblers. Participants completed a delay-discounting questionnaire involving choices between a smaller amount of money delivered immediately and a larger amount delivered later. A hyperbolic discounting function estimated delay-discounting rates based on participants' indifference points obtained via the questionnaires. Results showed significant effects of race/ethnicity on delay discounting. White gamblers discounted delayed money at lower rates than African Americans and Hispanics, even after controlling for confounding variables. These data suggest that among individuals who develop problem gambling, Whites are less impulsive than African Americans and Hispanics, at least in terms of choosing between delayed and immediate reinforcers. These results have implications for evaluating the onset and treatment of addictive disorders from a health-disparities perspective.

References

  1. J Clin Psychiatry. 2005 May;66(5):564-74 [PMID: 15889941]
  2. Drug Alcohol Depend. 2002 Sep 1;68(1):49-64 [PMID: 12167552]
  3. Am J Psychiatry. 2003 Jul;160(7):1353-4 [PMID: 12832257]
  4. Exp Clin Psychopharmacol. 2011 Jun;19(3):243-8 [PMID: 21517195]
  5. Psychiatr Serv. 2004 Feb;55(2):167-73 [PMID: 14762242]
  6. Psychopharmacology (Berl). 2011 Aug;216(3):305-21 [PMID: 21373791]
  7. Drug Alcohol Depend. 2009 Nov 1;105(1-2):89-96 [PMID: 19615829]
  8. Am J Addict. 2007 Jan-Feb;16(1):1-9 [PMID: 17364415]
  9. Psychopharmacology (Berl). 1999 Oct;146(4):348-61 [PMID: 10550486]
  10. J Abnorm Psychol. 2001 Aug;110(3):482-7 [PMID: 11502091]
  11. Addiction. 2001 Jan;96(1):73-86 [PMID: 11177521]
  12. J Nerv Ment Dis. 1985 Jul;173(7):412-23 [PMID: 4009158]
  13. Nature. 2002 Jan 17;415(6869):269-72 [PMID: 11796988]
  14. J Subst Abuse. 1997;9:103-10 [PMID: 9494942]
  15. Psychol Med. 2008 Sep;38(9):1351-60 [PMID: 18257941]
  16. Psychol Addict Behav. 2011 Dec;25(4):595-604 [PMID: 21988480]
  17. J Nerv Ment Dis. 2003 Jun;191(6):399-407 [PMID: 12826922]
  18. PLoS One. 2012;7(7):e40750 [PMID: 22848399]
  19. Child Dev. 2009 Jan-Feb;80(1):28-44 [PMID: 19236391]
  20. Psychopharmacology (Berl). 2005 Mar;178(2-3):193-201 [PMID: 15338104]
  21. Behav Pharmacol. 2006 Dec;17(8):651-67 [PMID: 17110792]
  22. Psychol Bull. 1975 Jul;82(4):463-96 [PMID: 1099599]
  23. Drug Alcohol Depend. 1999 Aug 2;56(1):25-32 [PMID: 10462089]
  24. Br J Addict. 1991 Aug;86(8):1017-28 [PMID: 1912747]
  25. J Exp Psychol Gen. 1999 Mar;128(1):78-87 [PMID: 10100392]
  26. Addict Behav. 2004 Aug;29(6):1171-5 [PMID: 15236819]
  27. Addict Behav. 2002 Jan-Feb;27(1):1-19 [PMID: 11800216]
  28. Psychol Aging. 1996 Mar;11(1):79-84 [PMID: 8726373]
  29. J Stud Alcohol. 1997 Sep;58(5):464-73 [PMID: 9273910]
  30. J Subst Abuse Treat. 2000 Mar;18(2):129-35 [PMID: 10716096]
  31. J Exp Anal Behav. 1972 Jan;17(1):15-22 [PMID: 16811561]
  32. Addiction. 2006 Sep;101 Suppl 1:152-60 [PMID: 16930172]
  33. Exp Clin Psychopharmacol. 2007 Apr;15(2):176-86 [PMID: 17469941]
  34. J Pers Soc Psychol. 1967 Jan;5(1):24-31 [PMID: 6031227]
  35. Psychon Bull Rev. 1996 Mar;3(1):100-4 [PMID: 24214810]
  36. Behav Processes. 2003 Oct 31;64(3):345-354 [PMID: 14580703]
  37. Clin Trials. 2009 Jun;6(3):252-60 [PMID: 19528134]
  38. Drug Alcohol Depend. 2012 Dec 1;126(3):333-9 [PMID: 22743160]
  39. Behav Processes. 2011 May;87(1):10-7 [PMID: 21354276]
  40. Psychol Bull. 2004 Sep;130(5):769-92 [PMID: 15367080]
  41. J Epidemiol Community Health. 2007 Mar;61(3):241-7 [PMID: 17325403]
  42. Behav Pharmacol. 1995 Dec;6(8):810-814 [PMID: 11224384]
  43. J Exp Psychol Anim Behav Process. 1986 Apr;12(2):116-24 [PMID: 3701262]
  44. Drug Alcohol Depend. 2009 Oct 1;104(3):197-203 [PMID: 19570621]
  45. J Exp Anal Behav. 1999 Mar;71(2):121-43 [PMID: 10220927]
  46. Am J Psychiatry. 1987 Sep;144(9):1184-8 [PMID: 3631315]
  47. J Gambl Stud. 2012 Mar;28(1):89-103 [PMID: 21253846]
  48. Am J Psychiatry. 2006 Feb;163(2):297-302 [PMID: 16449485]
  49. J Subst Abuse. 1998;10(2):163-73 [PMID: 9854701]
  50. Exp Clin Psychopharmacol. 2008 Apr;16(2):165-77 [PMID: 18489020]
  51. J Psychoactive Drugs. 2000 Apr-Jun;32(2):211-20 [PMID: 10908010]
  52. J Consult Clin Psychol. 2008 Apr;76(2):318-28 [PMID: 18377127]
  53. J Appl Behav Anal. 2003 Winter;36(4):449-58 [PMID: 14768665]

Grants

  1. T32-AA07290/NIAAA NIH HHS
  2. R01-DA024667/NIDA NIH HHS
  3. P50 DA009241/NIDA NIH HHS
  4. R01 DA021567/NIDA NIH HHS
  5. R01 DA024667/NIDA NIH HHS
  6. T32 AA007290/NIAAA NIH HHS
  7. M01 RR006192/NCRR NIH HHS
  8. R01-DA021567/NIDA NIH HHS
  9. R01-HD075630/NICHD NIH HHS
  10. P60-AA03510/NIAAA NIH HHS
  11. R01-DA022739/NIDA NIH HHS
  12. P60 AA003510/NIAAA NIH HHS
  13. R01 HD075630/NICHD NIH HHS
  14. R01-DA027615/NIDA NIH HHS
  15. R01 DA027615/NIDA NIH HHS
  16. P50 AA003510/NIAAA NIH HHS
  17. P30-DA023918/NIDA NIH HHS
  18. R01 DA022739/NIDA NIH HHS
  19. M01-RR06192/NCRR NIH HHS
  20. P30 DA023918/NIDA NIH HHS
  21. P50-DA09241/NIDA NIH HHS

MeSH Term

Adult
Black or African American
Delay Discounting
Female
Gambling
Hispanic or Latino
Humans
Male
Middle Aged
Reward
United States
White People